African American women with benign ethnic neutropenia had clinical benefit with Ibrance (palbociclib) in combination with endocrine therapy to treat advanced breast cancer. Ibrance (palbociclib) was ...

WASHINGTON (December 9, 2019) -- Women who receive palbociclib (Ibrance ®) to treat their advanced breast cancer and have a gene alteration that can lead to a condition known as benign ethnic ...

Black patients with prostate cancer are underrepresented in clinical trials due to eligibility requirements that exclude patients with benign ethnic neutropenia, according to a new study published in ...

Women who receive palbociclib (Ibrance ®) to treat their advanced breast cancer and have a gene alteration that can lead to a condition known as benign ethnic neutropenia (BEN), can safely receive the ...

This is Part 5 of Embedded Bias, a series revealing how race-based clinical algorithms pervade medicine and why it's so difficult to change them. A busy medical student, Vanessa Apea wasn’t her usual ...

Clinical implications and prevalence of benign ethnic neutropenia (BEN) in breast cancer patients of Middle Eastern ethnicity. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I.

A Protected Class, An Unprotected Condition, and A Biomarker - A Method/Formula for Increased Diversity in Clinical Trials for the African American Subject with Benign Ethnic Neutropenia (BEN) - ...

A study led by researchers at Cardiff University means that more people of African descent who have treatment-resistant schizophrenia could be safely given the drug best proven to manage their ...

A new study means that more people of African descent who have treatment-resistant schizophrenia could be safely given the drug best proven to manage their symptoms. A study led by researchers at ...